A
revised Draft PIC/S Guidance on Good Practices for Data Management and
Integrity in Regulated GMP/GDP Environments (PI 041-1 (Draft 3) has been
prepared by the PIC/S Working Group on Data Integrity, co-led by Australia TGA
and UK MHRA.
Authorities
on a trial basis for a new implementation trial period. The consultation period
will last 3 months and run from 30 November 2018 to 28 February 2019.
Posted by Dr. Tim Sandle, Pharmaceutical Microbiology
No comments:
Post a comment
Pharmaceutical Microbiology Resources